68 related articles for article (PubMed ID: 9013411)
1. CGP 39653 binding in the chick CNS after NMDA receptor antagonist treatment.
White BH; Vogel MW
J Neural Transm (Vienna); 1996; 103(11):1247-53. PubMed ID: 9013411
[TBL] [Abstract][Full Text] [Related]
2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
3. Purkinje cell dendritic arbors in chick embryos following chronic treatment with an N-methyl-D-aspartate receptor antagonist.
Vogel MW; Prittie J
J Neurobiol; 1995 Apr; 26(4):537-52. PubMed ID: 7602317
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
Balcar VJ; Dias LS; Li Y; Bennett MR
Neuroreport; 1995 Dec; 7(1):69-72. PubMed ID: 8742419
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the N-methyl-D-aspartate (NMDA) receptor in the embryonic chick brain.
Jacobsson SO; Hedin H; Sellström A; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):625-33. PubMed ID: 9686938
[TBL] [Abstract][Full Text] [Related]
6. A partial agonist model used in the allosteric modulation of the NMDA receptor.
Robichon R; Randall PK; Leslie SW
Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
[TBL] [Abstract][Full Text] [Related]
7. Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding protein.
Kumar KN; Johnson PS; Chen X; Pal R; Ahmad M; Ragland T; Bigge C; Michaelis EK
Biochem Biophys Res Commun; 1998 Dec; 253(2):463-9. PubMed ID: 9878559
[TBL] [Abstract][Full Text] [Related]
8. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
9. Glutamate receptors in the cingulate cortex, hippocampus, and cerebellar vermis of alcoholics.
Freund G; Anderson KJ
Alcohol Clin Exp Res; 1999 Jan; 23(1):1-6. PubMed ID: 10029196
[TBL] [Abstract][Full Text] [Related]
10. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
Dall'olio R; Rimondini R; Gandolfi O
Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
[TBL] [Abstract][Full Text] [Related]
11. Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity.
Maj J; Klimek V; Gołembiowska K; Rogóz Z; Skuza G
Pol J Pharmacol; 1993; 45(5-6):455-66. PubMed ID: 7912134
[TBL] [Abstract][Full Text] [Related]
12. Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus.
Gould E; Cameron HA; McEwen BS
J Comp Neurol; 1994 Feb; 340(4):551-65. PubMed ID: 7911808
[TBL] [Abstract][Full Text] [Related]
13. Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior, cingulate cortex.
Wedzony K; Czyrak A
J Physiol Pharmacol; 1996 Sep; 47(3):525-33. PubMed ID: 8877908
[TBL] [Abstract][Full Text] [Related]
14. Neuronal nitric oxide synthase is permanently decreased in the cerebellum of rats subjected to chronic neonatal blockade of N-methyl-D-aspartate receptors.
Virgili M; Facchinetti F; Sparapani M; Tregnago M; Lucchi R; Dall'Olio R; Gandolfi O; Contestabile A
Neurosci Lett; 1998 Dec; 258(1):1-4. PubMed ID: 9876037
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 'non-N-methyl-D-Aspartate' binding sites for gacyclidine enantiomers in the rat cerebellar and telencephalic structures.
Hirbec H; Kamenka JM; Privat A; Vignon J
J Neurochem; 2001 Apr; 77(1):190-201. PubMed ID: 11279275
[TBL] [Abstract][Full Text] [Related]
16. Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide.
Terse PS; Komiskey HL
Brain Res; 1997 Jan; 744(2):347-50. PubMed ID: 9027396
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.
Dumont M; Lemaire S
Eur J Pharmacol; 1994 Dec; 271(1):241-4. PubMed ID: 7698209
[TBL] [Abstract][Full Text] [Related]
18. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116: in vivo and in vitro studies.
Maier CM; Sun GH; Kunis DM; Giffard RG; Steinberg GK
J Neurochem; 1995 Aug; 65(2):652-9. PubMed ID: 7616221
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum.
Monti B; Contestabile A
Eur J Neurosci; 2000 Sep; 12(9):3117-23. PubMed ID: 10998095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
